Patients The humans the algorithms can't reach Patients don’t start, stay on, or return to therapy because they receive a notification at the right time.
Patients Delivering the right behavioural ingredients for the moment,... Lirio's Dr Amy Bucher discusses the risks of the declining trust in healthcare institutions from a behavioural science perspective.
Patients The NHS, system burden, and a transformation prescription, w... Dr Ruth Chambers OBE, co-director of Raparu Consult CIC and a visiting professor at Staffordshire University, discusses her book on the NHS.
Patients How connection can create impact in healthcare: Patient advo... At ESMO 2025 in Berlin, VML Health presented the inaugural Patient Advocacy Summit.
Patients DTC pharma is America’s newest care pathway. TrumpRx has exp... Today’s DTP platforms vary widely in standards, screening protocols, clinical follow-up, data use, and integration with a patient’s broader care team
Patients How direct-to-patient prescribing is shifting the status quo... To remain competitive, biopharma must move beyond disjointed support services and take direct responsibility for the patient journey.
News Enhertu OK ends 10-year EU gap in frontline breast cancer Enhertu plus Perjeta has become the first new frontline therapy approved for advanced HER2-positive breast cancer in the EU for over a decade.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
